Results 1 to 10 of about 108,435 (311)

Intravenous immunoglobulin: Revisited – My experience

Indian Journal of Dermatology, 2021
Background: Many a times while treating dermatoses conventional therapies are either contraindicated or not effective. Intravenous immunoglobulin (IVIG) is a good alternative available to tide over crises.
Sanjeev S Vaishampayan, Surendra Singh Bhati, Radha R Lachhiramani, Shivank Shrivastava, Prateek Jain, Ajay Singh Raghuwanshi   +5 more
doaj   +3 more sources

Intravenous immunoglobulin in dermatology

Indian Journal of Dermatology, 2009
Dhar Sandipan
doaj   +3 more sources

High-dose immunoglobulin-dependent chronic inflammatory demyelinating polyneuropathy successfully managed with subcutaneous immunoglobulin using pharmacokinetic analysis

eNeurologicalSci, 2022
Immunoglobulin G therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) often requires individual dose adjustments because of the heterogeneity of pathogenesis and varying catabolic rates.
Satomi Hiya, Satoru Fujiwara, Fumiaki Tanaka, Nobuo Kohara, Michi Kawamoto   +4 more
doaj   +1 more source

Use of intravenous immunoglobulin in neonates with haemolytic disease and immune thrombocytopenia [PDF]

Vojnosanitetski Pregled, 2013
Background/Aim. Intravenous immunoglobulin is a blood product made of human polyclonal immunoglobulin G. The mode of action of intravenous immunoglobulin is very complex.
Marković-Sovtić Gordana, Janković Borisav, Rakonjac Zorica, Martić Jelena, Pejić Katarina   +4 more
doaj   +1 more source

Serum immunoglobulin G predicts mortality and stratifies intravenous immunoglobulin benefit in sepsis patients [PDF]

Military Medical Research
Yuan-Yuan Hu, Ming-Min Pang, Hao-Yu Wang, Wen-Xiong Li, Hao Wang   +4 more
doaj   +2 more sources

Intravenous Immunoglobulin Therapy in Myocarditis

Iranian Journal of Allergy, Asthma and Immunology, 2020
Myocarditis is an inflammatory disease of the myocardium with lymphocyte infiltration and myocyte necrosis leading to a wide range of clinical presentations including heart failure, arrhythmia, and cardiogenic shock.
Amir Hossein Mansourabadi, Ladan Gol Mohammad pour Afrakoti, Abbas Shahi, Reza Shabanian, Aliakbar Amirzargar   +4 more
doaj   +1 more source

Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study

Frontiers in Immunology, 2022
BackgroundThe benefits of intravenous immunoglobulin administration are controversial for critically ill COVID-19 patients.MethodsWe analyzed retrospectively the effects of immunoglobulin administration for critically ill COVID-19 patients.
Yan Chen, Jianfeng Xie, Wenjuan Wu, Shusheng Li, Yu Hu, Ming Hu, Jinxiu Li, Yi Yang, Tingrong Huang, Kun Zheng, Yishan Wang, Hanyujie Kang, Yingzi Huang, Li Jiang, Wei Zhang, Ming Zhong, Ling Sang, Xia Zheng, Chun Pan, Ruiqiang Zheng, Xuyan Li, Zhaohui Tong, Haibo Qiu, Li Weng, Bin Du   +24 more
doaj   +1 more source

Intravenous immunoglobulin induced pancytopenia while preventing development of gestational alloimmune liver disease: A case report

Case Reports in Women's Health, 2022
Gestational alloimmune liver disease is a rare complication associated with reactive maternal immunoglobulins resulting in neonatal liver pathology. The mainstay treatment for prevention in future pregnancies is intravenous immunoglobulins.
Minhazur Sarker, Chelsea DeBolt, Noel Strong   +2 more
doaj   +1 more source

INTRAVENOUS IMMUNOGLOBULIN THERAPY IN MEDICAL PRAXIS [PDF]

Journal of IMAB, 2016
Intravenous immunoglobulin (IVIG) is a blood product prepared from the serum of of a thousand or more blood donors. The IVIG that is available contains complete immunoglobulin G( IgG )molecules which has intact Fc-dependent effector functions.
Lidija Kareva
doaj   +1 more source

Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study)

Human Vaccines & Immunotherapeutics, 2020
Introduction Although there are studies about sepsis treatment in different age groups, data on immunoglobulin-M (IgM)-enriched intravenous immunoglobulin use in pediatric intensive care units (PICUs) are limited.
Emin Abdullayev, Omer Kilic, Gurkan Bozan, Eylem Kiral, Merve Iseri Nepesov, Ener Cagri Dinleyici   +5 more
doaj   +1 more source